Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 11/21/23

Jyotsna R. Sandil, M.D.

Regulatory Affairs Specialist

Dr. Jyotsna Sandil joined the Drug Regulatory Group of the Regulatory Affairs Branch at CTEP in March 2023. She graduated from Kuban State Medical Academy in Russia where she was awarded Doctor of Medicine. She worked as a medical resident officer at Medwin Hospital in Hyderabad, India.

Prior to joining CTEP, Dr. Sandil served as a Senior Clinical Research Manager, Site Oversight Manager & Clinical Research Coordinator at a Private Research Institution (Manassas Clinical Research Center) over the period of 16 years. She also worked as a Clinical Research Coordinator at Sislen & Associates. She has extensive experience in operational and scientific support of Clinical research studies in different therapeutic areas of Internal Medicine. She worked with multiple sites, various Principal Investigators, Sub-Investigators in assisting with IRB submissions, protocol revisions, and renewals. She also facilitated regulatory management using FDA and USDA requirements at the Institution.

About the Branch Chief

Bhanu Ramineni, M.S., M.S. Bhanu Ramineni, M.S., M.S., became the Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. Ms. Ramineni comes with significant experience in FDA Regulatory Affairs, as well as preclinical and clinical development of vaccines with a special focus in immunology. More…